Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 67296-1893

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 67296-1893). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (5 mg (100 Tablet Bottle))

Label for Cyclobenzaprine Hydrochloride Tablets USP 5 mg film-coated tablets, by Rising Pharma Holdings, Inc. The package contains 100 tablets. The label includes storage instructions, dosage strength, NDC 16571-782-01, and barcode. The product is for prescription use only.*

FDA Label Image

Package Label-principal Display Panel (10 mg (100 Tablet Bottle))

Label for Cyclobenzaprine Hydrochloride Tablets, USP 10 mg, film-coated oral tablets. The label indicates a bottle containing 100 tablets, marked Rx only. Manufacturer is Rising Pharmaceuticals with an NDC of 16571-783-01. Storage instructions and distribution details by Rising Pharma Holdings, Inc., East Brunswick, NJ, are also included.*

FDA Label Image

Chemical Structure (Cyclobenz Str)

Chemical structure diagram of Cyclobenzaprine Hydrochloride, showing the molecular framework with rings and attached functional groups as depicted in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.